Tuesday, August 24, 2021 Headlines
FDA Grants Full Approval To Pfizer-Biontech Vaccine; IMF Realizes Special Drawing Rights Allocation Of 650 Billion Dollars.
FDA Grants Full Approval To Pfizer-Biontech Vaccine; IMF Realizes Special Drawing Rights Allocation Of 650 Billion Dollars.
Markets Focus On Fed Decision; IMF Revises Japan's 2021 Growth Rate; Apple, Microsoft And Alphabet Increase Net Profits.
IMF Supported The $650 Billion Plan; Trump Organization Could Face Criminal Charges This Week; Sydney Goes into Two Weeks Lockdown.
British Economy Expected to Grow 4 percent; ECB Vice President Guindos: "2021 Inflation Will be Above the Last ECB Forecast"; ...
UBS Expects Another Global Equity Rotation; IMF President Georgieva: ‘’The Global Economy is at the Crossroads’’; Apple Acquired More than ...
Subscribe to our newsletter and get notified about the next update.
© 2021 FTD Limited
FTD Articles is a website prepared by FTD Limited's research team. FTD Limited is an online brokerage company offering products of Forex, Spot Metals and CFDs.
The ideas and the information shown here have no responsibility of any of the trading decisions made by the investors or the visitors of this site. Therefore, under no circumstances will FTD Limited nor FTD Articles be held responsible or liable in any way for any claims, damages, losses, costs or liabilities resulting or arising directly or indirectly from the use of website content. We recommend that you seek advice if you have not involved with trading before in order to prevent potential risks that may arise.
© 2021 FTD Limited
FTD Articles is a website prepared by FTD Limited's research team. FTD Limited is an online brokerage company offering products of Forex, Spot Metals and CFDs.
The ideas and the information shown here have no responsibility of any of the trading decisions made by the investors or the visitors of this site. Therefore, under no circumstances will FTD Limited nor FTD Articles be held responsible or liable in any way for any claims, damages, losses, costs or liabilities resulting or arising directly or indirectly from the use of website content. We recommend that you seek advice if you have not involved with trading before in order to prevent potential risks that may arise.